COVID-19 pandemic and elective spinal surgery cancelations - what happens to the patients?

COVID-19 Elective surgery Pandemic Rescheduling surgery Surgery cancellation Surgery deferment,

Journal

The spine journal : official journal of the North American Spine Society
ISSN: 1878-1632
Titre abrégé: Spine J
Pays: United States
ID NLM: 101130732

Informations de publication

Date de publication:
12 2021
Historique:
received: 20 04 2021
revised: 24 07 2021
accepted: 27 07 2021
pubmed: 3 8 2021
medline: 15 12 2021
entrez: 2 8 2021
Statut: ppublish

Résumé

The COVID-19 pandemic caused nationwide suspensions of elective surgeries due to reallocation of resources to the care of COVID-19 patients. Following resumption of elective cases, a significant proportion of patients continued to delay surgery, with many yet to reschedule, potentially prolonging their pain and impairment of function and causing detrimental long-term effects. The aim of this study was to examine differences between patients who have and have not rescheduled their spine surgery procedures originally cancelled due to the COVID-19 pandemic, and to evaluate the reasons for continued deferment of spine surgeries even after the lifting of the mandated suspension of elective surgeries. Retrospective case series at a single institution PATIENT SAMPLE: Included were 133 patients seen at a single institution where spine surgery was canceled due to a state-mandated suspension of elective surgeries from March to June, 2020. The measures assessed included preoperative diagnoses and neurological dysfunction, surgical characteristics, reasons for surgery deferment, and PROMIS scores of pain intensity, pain interference, and physical function. Patient electronic medical records were reviewed. Patients who had not rescheduled their canceled surgery as of January 31, 2021, and did not have a reason noted in their charts were called to determine the reason for continued surgery deferment. Patients were divided into three groups: early rescheduled (ER), late rescheduled (LR), and not rescheduled (NR). ER patients had a date of surgery (DOS) prior to the city's Phase 4 reopening on July 20, 2020; LR patients had a DOS on or after that date. Statistical analysis of the group findings included analysis of variance with Tukey's honestly significant difference (HSD) post-hoc test, independent samples T-test, and chi-square analysis with significance set at p≤.05. Out of 133 patients, 47.4% (63) were in the ER, 15.8% (21) in the LR, and 36.8% (49) in the NR groups. Demographics and baseline PROMIS scores were similar between groups. LR had more levels fused (3.6) than ER (1.6), p= .018 on Tukey HSD. NR (2.1) did not have different mean levels fused than LR or ER, both p= >.05 on Tukey HSD. LR had more three column osteotomies (14.3%) than ER and (1.6%) and NR (2.0%) p=.022, and fewer lumbar microdiscectomies (0%) compared to ER (20.6%) and NR (10.2%), p=.039. Other surgical characteristics were similar between groups. LR had a longer length of stay than ER (4.2 vs 2.4, p=.036). No patients in ER or LR had a nosocomial COVID-19 infection. Of NR, 2.0% have a future surgery date scheduled and 8.2% (4) are acquiring updated exams before rescheduling. 40.8% (20; 15.0% total cohort) continue to defer surgery over concern for COVID-19 exposure and 16.3% (8) for medical comorbidities. 6.1% (3) permanently canceled for symptom improvement. 8.2% (4) had follow-up recommendations for non-surgical management. 4.1% (2) are since deceased. Over 1/3 of elective spine surgeries canceled due to COVID-19 have not been performed in the 8 months from when elective surgeries resumed in our institution to the end of the study. ER patients had less complex surgeries planned than LR. NR patients continue to defer surgery primarily over concern for COVID-19 exposure. The toll on the health of these patients as a result of the delay in treatment and on their lives due to their inability to return to normal function remains to be seen.

Sections du résumé

BACKGROUND CONTEXT
The COVID-19 pandemic caused nationwide suspensions of elective surgeries due to reallocation of resources to the care of COVID-19 patients. Following resumption of elective cases, a significant proportion of patients continued to delay surgery, with many yet to reschedule, potentially prolonging their pain and impairment of function and causing detrimental long-term effects.
PURPOSE
The aim of this study was to examine differences between patients who have and have not rescheduled their spine surgery procedures originally cancelled due to the COVID-19 pandemic, and to evaluate the reasons for continued deferment of spine surgeries even after the lifting of the mandated suspension of elective surgeries.
STUDY DESIGN/SETTING
Retrospective case series at a single institution PATIENT SAMPLE: Included were 133 patients seen at a single institution where spine surgery was canceled due to a state-mandated suspension of elective surgeries from March to June, 2020.
OUTCOME MEASURES
The measures assessed included preoperative diagnoses and neurological dysfunction, surgical characteristics, reasons for surgery deferment, and PROMIS scores of pain intensity, pain interference, and physical function.
METHODS
Patient electronic medical records were reviewed. Patients who had not rescheduled their canceled surgery as of January 31, 2021, and did not have a reason noted in their charts were called to determine the reason for continued surgery deferment. Patients were divided into three groups: early rescheduled (ER), late rescheduled (LR), and not rescheduled (NR). ER patients had a date of surgery (DOS) prior to the city's Phase 4 reopening on July 20, 2020; LR patients had a DOS on or after that date. Statistical analysis of the group findings included analysis of variance with Tukey's honestly significant difference (HSD) post-hoc test, independent samples T-test, and chi-square analysis with significance set at p≤.05.
RESULTS
Out of 133 patients, 47.4% (63) were in the ER, 15.8% (21) in the LR, and 36.8% (49) in the NR groups. Demographics and baseline PROMIS scores were similar between groups. LR had more levels fused (3.6) than ER (1.6), p= .018 on Tukey HSD. NR (2.1) did not have different mean levels fused than LR or ER, both p= >.05 on Tukey HSD. LR had more three column osteotomies (14.3%) than ER and (1.6%) and NR (2.0%) p=.022, and fewer lumbar microdiscectomies (0%) compared to ER (20.6%) and NR (10.2%), p=.039. Other surgical characteristics were similar between groups. LR had a longer length of stay than ER (4.2 vs 2.4, p=.036). No patients in ER or LR had a nosocomial COVID-19 infection. Of NR, 2.0% have a future surgery date scheduled and 8.2% (4) are acquiring updated exams before rescheduling. 40.8% (20; 15.0% total cohort) continue to defer surgery over concern for COVID-19 exposure and 16.3% (8) for medical comorbidities. 6.1% (3) permanently canceled for symptom improvement. 8.2% (4) had follow-up recommendations for non-surgical management. 4.1% (2) are since deceased.
CONCLUSION
Over 1/3 of elective spine surgeries canceled due to COVID-19 have not been performed in the 8 months from when elective surgeries resumed in our institution to the end of the study. ER patients had less complex surgeries planned than LR. NR patients continue to defer surgery primarily over concern for COVID-19 exposure. The toll on the health of these patients as a result of the delay in treatment and on their lives due to their inability to return to normal function remains to be seen.

Identifiants

pubmed: 34339887
pii: S1529-9430(21)00843-3
doi: 10.1016/j.spinee.2021.07.019
pmc: PMC8321964
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2003-2009

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

J Arthroplasty. 2021 Feb;36(2):397-402.e2
pubmed: 32807565
Bone Jt Open. 2020 Nov 01;1(6):267-271
pubmed: 33215113
Antimicrob Resist Infect Control. 2021 Jan 6;10(1):7
pubmed: 33407833
J Arthroplasty. 2020 Jul;35(7S):S49-S55
pubmed: 32376163
World Neurosurg. 2020 Nov;143:e550-e560
pubmed: 32777390
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1725-1729
pubmed: 33211680
Int Orthop. 2020 Oct;44(10):1905-1913
pubmed: 32683461
HSS J. 2020 Nov;16(Suppl 1):45-51
pubmed: 32952467
HSS J. 2020 Nov;16(Suppl 1):77-84
pubmed: 32952468
Int Orthop. 2020 Dec;44(12):2505-2513
pubmed: 32914217

Auteurs

Zoe A Norris (ZA)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Ethan Sissman (E)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Brooke K O'Connell (BK)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Nicole A Mottole (NA)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Hershil Patel (H)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Eaman Balouch (E)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Kimberly Ashayeri (K)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Constance Maglaras (C)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Themistocles S Protopsaltis (TS)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Aaron J Buckland (AJ)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA.

Charla R Fischer (CR)

Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA. Electronic address: charla.fischer@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH